A randomised, double-blind, placebo-controlled, cross-over trial of zibotentan in microvascular angina (PRIZE)

Project: Research

Project Details

StatusFinished
Effective start/end date1/06/201930/09/2022

Collaborative partners

  • King's College London
  • Greater Glasgow Health Board
  • University of Oxford
  • OXFORD UNIVERSITY HOSPITAL
  • Blackpool Teaching Hospitals NHS Foundation Trust
  • Royal Free London NHS Foundation Trust
  • AstraZeneca UK Ltd
  • Siemens Healthcare Ltd
  • University of Glasgow (lead)

Funding

  • MRC Medical Research Council: £2,714,380.00